Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections (Q38048860)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2012

Language	Label	Description	Also known as
English	Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections	scientific article published on October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections (English)

1 reference

Europe PubMed Central

27 August 2017

1 reference

based on heuristic

inferred from title

Enterobacteriaceae

0 references

Enrico Maria Trecarichi

object named as

Enrico Maria Trecarichi

1

0 references

object named as

Roberto Cauda

2

0 references

Mario Tumbarello

3

object named as

Mario Tumbarello

1 reference

Europe PubMed Central

27 August 2017

publication date

1 October 2012

1 reference

Europe PubMed Central

27 August 2017

number of pages

17

1 reference

based on heuristic

inferred from page(s)

Future Microbiology

1 reference

Europe PubMed Central

27 August 2017

7

1 reference

Europe PubMed Central

27 August 2017

1173-1189

1 reference

Europe PubMed Central

27 August 2017

10

1 reference

Europe PubMed Central

27 August 2017

Clinical significance of extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Extended-spectrum beta-lactamases in long-term-care facilities

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Identifiers

10.2217/FMB.12.100

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38048860&oldid=2143491767"